QS Investors’s BioTelemetry, Inc. BEAT Stock Holding History

QS Investors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,700	Closed	-$77K	–	1668
2020 Q2	$77K	Buy	+1,700	New	+$76.2K	﹤0.01%	1389

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

QS Investors's BEAT Position: Q3 2020 in Review

QS Investors sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 1,700 shares — an estimated $77K sold.

QS Investors first reported a position in BEAT in Q2 2020 and held it in 1 quarter. The position peaked at $77K in Q2 2020. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

QS Investors reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
QS Investors sold 1,700 BioTelemetry, Inc. shares in Q3 2020, an estimated $77K.
QS Investors first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 1 quarter.
QS Investors's BioTelemetry, Inc. position peaked at $77K in Q2 2020.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.